Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (7)
  • 2025 (69)
  • 2024 (61)
  • 2023 (58)
  • 2022 (70)
  • 2021 (77)
  • 2020 (84)
  • 2019 (93)
  • 2018 (88)
  • 2017 (100)
  • 2016 (72)
  • 2015 (75)
  • 2014 (112)
  • 2013 (124)
  • 2012 (47)
  • 2011 (119)

Subject

  • Drug Trafficking (132)
  • Synthetic drugs (125)
  • Arrests/Convictions - Major (54)
  • Guns/Weapons (37)
  • Prescription Drugs (35)
  • Seizures (Drugs/Property) (30)
  • Take Back Day (30)
  • Fake Pills (26)
  • Outreach/Drug Prevention (25)
  • Major Law Enforcement Operation (22)
  • Guilty Plea (21)
  • Public and Media Affairs - also see Congressional Affairs (18)
  • Diversion Division (17)
  • Pharmaceuticals/Pharmacists/Physicians (16)
  • Overdose (15)
  • OCDETF/Task Force (14)
  • Congressional Affairs (13)
  • Money Laundering (13)
  • Fentanyl Awareness (12)
  • Gangs (12)
  • Press Conferences (11)
  • Extraditions (10)
  • Red Ribbon (9)
  • One Pill Can Kill (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Fentanyl Free America (7)
  • Task Forces/Task Force Officers (6)
  • Narcoterrorism (5)
  • Critical Incident (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Campaigns (3)
  • Counterfeit Pills (3)
  • Dark Web- Internet Trafficking (3)
  • Terrorism (3)
  • HIDTA (2)
  • Scam Calls (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (167)
  • Methamphetamine (135)
  • Heroin (72)
  • Cocaine (66)
  • Marijuana (Cannabis) (26)
  • Oxycodone (19)
  • Opioids (11)
  • Synthetic Opioids (6)
  • Ecstasy/MDMA (5)
  • Marijuana Concentrates (5)
  • Ketamine (4)
  • LSD (2)
  • GHB (1)
  • K2/Spice (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • Miami (840)
  • Seattle (813)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribbean (79)
  • Caribbean (1)
  • San Francisco (847)
  • Headquarters (414)
Clear All Results
1256 Results - Showing 541 to 550
PRESS RELEASE

Two charged with methamphetamine distribution conspiracy, firearms violations, and assault on a federal officer

FRESNO, Calif. — A federal grand jury returned a six-count indictment today against Ruben Gonzalo Duran-Sanchez, 42, and Daniel Delgado, 27, both Mexican nationals, charging them with conspiracy to distribute and possess with intent to distribute methamphetamine and possession of firearms in furtherance of a drug trafficking offense, U.S. Attorney...
PRESS RELEASE

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...
PRESS RELEASE

Santa Rosa doctor indicted for unlawfully prescribing fentanyl and oxycodone

SAN FRANCISCO – A federal grand jury indicted Santa Rosa doctor Thomas Keller, charging him with distributing Schedule II and IV controlled substances outside the scope of his professional practice and without a legitimate medical need, announced United States Attorney Alex G. Tse, Drug Enforcement Administration (DEA) Special Agent in...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...
PRESS RELEASE

Alameda resident sentenced for selling prescription drugs without a license and related charges

SAN FRANCISCO – Kenzo Mateo Tokuda was sentenced to 69 months in prison for possessing with intent to distribute alprazolam (commonly known as “Xanax”) and carrying a firearm during and in relation to a drug trafficking crime, announced United States Attorney Alex G. Tse and Drug Enforcement Administration Special Agent...
PRESS RELEASE

Mexican national residing in Modesto is sentenced to 17.5 years in prison for methamphetamine trafficking

SACRAMENTO, Calif. — Feliciano Ochoa Reyes, 34, of Mexico and Modesto was sentenced today by U.S. District Judge Garland E. Burrell, Jr. to 17-and-a-half years in prison for conspiring to distribute methamphetamine, U.S. Attorney McGregor W. Scott and U.S. Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced. According...
PRESS RELEASE

Former medical doctor sentenced to over three years prison for unlawfully prescribing oxycodone

SAN FRANCISCO – United States Attorney Alex G. Tse and U.S. Drug Enforcement Administration Special Agent in Charge Chris Nielsen announced that Christopher Owens was sentenced to 41 months in prison for unlawfully prescribing oxycodone hydrochloride without a medical purpose. Owens pleaded guilty on March 20, 2018. According to his...
PRESS RELEASE

Two Afghan heroin traffickers sentenced in Manhattan federal court for conspiring to import heroin into the United States

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

Justice Department announces release of new fentanyl safety video for first responders

WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...

Pagination

  • First page «
  • Previous
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Current page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster